Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)
Clinical trial NCT04607005 · COMPLETED
Trial details
- NCT number
- NCT04607005
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-08
- Primary completion
- 2023-04-12
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.